Dropletpharma Corp.
Los Angeles, CA Dropletpharma Corp.
- UEI
- ZJ7YCLEP1DB4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 15556 Briarwood Dr, Sherman Oaks, CA 91403, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Demonstrating miniaturized production of a KOR pet tracer as a proof-of-concept for low-cost distribution of nascent pet… | National Institute on Drug Abuse | $858,817 | |
| Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry - project… | National Institute of Biomedical Imaging and Bioenginering | $275,773 | |
| Microchip electrophoresis as basis for fully integrated, fully automated, low-cost radiopharmaceutical QC platform -… | National Cancer Institute | $551,532 |
About Dropletpharma Corp.
Dropletpharm Inc. is a for-profit corporate entity developing microfluidic technologies for manufacturing radiopharmaceuticals and radiochemical production. The company is commercializing a benchtop radiopharmacy platform based on droplet microfluidics to enable low-cost and distributed production of radiotracers.
Through recent federal grant funding, Dropletpharm Inc. has advanced several innovative projects related to radiopharmaceutical manufacturing and quality control. With awards from the National Institutes of Health (NIH), the company has demonstrated microfluidic production of Kappa Opioid Receptor (KOR) Positron Emission Tomography (PET) tracers for studying drug abuse and addiction. Additionally, Dropletpharm has developed droplet-based methods for radiometal labeling of PET tracers like [68Ga]Ga-PSMA-11 for prostate cancer imaging. The company has also been funded by the NIH National Cancer Institute to create a microfluidics quality control platform utilizing microchip electrophoresis for rapid analysis and purity testing of radiopharmaceuticals, eliminating the need for costly infrastructure. Overall, Dropletpharm's federally-funded work aims to dramatically reduce costs and enable distributed manufacturing of diverse radiopharmaceuticals for research and clinical applications.
Quick answers
What is Dropletpharma Corp.'s UEI?
Dropletpharma Corp.'s Unique Entity ID (UEI) in SAM.gov is ZJ7YCLEP1DB4.
Where is Dropletpharma Corp. located?
Dropletpharma Corp.'s physical address in SAM.gov is 15556 Briarwood Dr, Sherman Oaks, CA 91403, USA.
Is Dropletpharma Corp. registered in SAM.gov?
Yes. Dropletpharma Corp.'s SAM.gov registration is active through December 17, 2026.
What is Dropletpharma Corp.'s most recent federal award?
Dropletpharma Corp.'s most recent federal grant award is Demonstrating miniaturized production of a KOR pet tracer as a proof-of-concept for low-cost distribution of nascent pet… (R41DA059980), from National Institute on Drug Abuse, on September 30, 2023.
On GovTribe
See Dropletpharma Corp.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors